A single dose of CBLB502 was given to mice and monkeys by researchers before radiotherapy, which dramaically reduced damage to cells.
This drug works by stopping apoptosis.
Survival rates for mice and monkeys respectively were 87% and 70% respecively
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment